Hallman, T. G., Golovko, G., Song, J., Palackic, A., Wolf, S. E., & El Ayadi, A. (2024). Metformin is associated with reduced risk of mortality and morbidity in burn patients compared to insulin. Burns (03054179), 50(7), 1779. https://doi.org/10.1016/j.burns.2024.05.015
Chicago Style (17th ed.) CitationHallman, Taylor G., Georgiy Golovko, Juquan Song, Alen Palackic, Steven E. Wolf, and Amina El Ayadi. "Metformin Is Associated with Reduced Risk of Mortality and Morbidity in Burn Patients Compared to Insulin." Burns (03054179) 50, no. 7 (2024): 1779. https://doi.org/10.1016/j.burns.2024.05.015.
MLA (9th ed.) CitationHallman, Taylor G., et al. "Metformin Is Associated with Reduced Risk of Mortality and Morbidity in Burn Patients Compared to Insulin." Burns (03054179), vol. 50, no. 7, 2024, p. 1779, https://doi.org/10.1016/j.burns.2024.05.015.